For decades, the vast nature of chemical space has presented intractable challenges to addressing a wide range of targets for diseases with high unmet need. Psivant Therapeutics is one of a select group of biotech companies advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design that is tightly coupled to chemistry and biology research and development. From a storytelling and branding perspective, a key challenge is how to clearly articulate a combination of complex science, collaborative culture and steadfast commitment to developing medicines for patients in need.
Wyant Simboli created a new name and corporate identity and developed the brand story and corporate website to express how Psivant is applying its computationally robust physics-based free energy methods to develop better therapeutics, atom by atom. We worked closely with Psivant CEO, Woody Sherman, to create a new company name, corporate identity and develop the brand story and corporate website to express how Psivant is applying its computational physics + AI approach to develop better therapeutics, atom by atom.